Primecap Management Co/Ca/
Source: SEC Form 13F · as of Mar 2026Primecap Management Co/Ca/ holds 12 biotech & pharma companies tracked by BioSniper, totaling $4.19B in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$4.19B
BioSniper AIPage evidence connected
Prepared research question
What matters most for BeOne Medicines Ltd. (ONC)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ONCBeOne Medicines Ltd. | 4,975,181 | $1.48B |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 25,204,538 | $1.39B |
| BMRNBIOMARIN PHARMACEUTICAL INC | 14,194,005 | $801.8M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 3,417,509 | $297.2M |
| IMCRImmunocore Holdings plc | 3,693,241 | $111.4M |
| BBIOBridgeBio Pharma, Inc. | 569,180 | $42.3M |
| PVLAPALVELLA THERAPEUTICS, INC. | 195,030 | $24.3M |
| NKTRNEKTAR THERAPEUTICS | 279,150 | $20.1M |
| FOLDAMICUS THERAPEUTICS, INC. | 585,400 | $8.5M |
| SNYSanofi | 97,168 | $4.7M |
| LENZLENZ Therapeutics, Inc. | 472,200 | $4.3M |
| ZNTLZentalis Pharmaceuticals, Inc. | 957,420 | $2.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.